MetaCap

Abbott Laboratories Statistics

NYSE: ABTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

98.49-0.24 (-0.24%)

At close: Oct 8, 4:02 PM ET · Delayed 15 min

Abbott Laboratories by the numbers

Abbott Laboratories has a market capitalization of $170.43 billion based on 1.73B shares outstanding. Its trailing P/E ratio is 31.9, above the 8-company peer median of 19.7, and its forward P/E is 16.2. The stock trades 7.3% below its 50-day average and 4.8% below its 200-day average.

Average daily trading volume is 9.64M shares, or about $949.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABT valuation vs. peer median

ABT compared with the median of 8 peer companies
MetricABTPeer medianDifference
Market cap$170.43B$124.63B+37%
P/E (TTM)31.919.7+62%
Forward P/E16.210.6+54%
Dividend yield2.52%4.21%-40%
Avg. volume9.64M3.64M+165%

Peer median across 8 companies: NVO, PFE, VRTX, BMY, SNY, AZN, GSK, REGN.

Valuation

Market cap
$170.43B
Price / sales (latest FY)
3.84

Price and trading

Previous close
98.73
Open
98.56
Day range
97.20 – 99.20
52-week range
81.97 – 134.50
52-week change
-26.65%
Beta
—
Volume
11.94M

Dividends and events

Annual dividend
$2.48
Next earnings date
Oct 21, 2026

Additional statistics

Market Cap
170.43B
Pe
31.87
Forward Pe
16.24
Eps
3.09
Dividend Yield
2.55%
Dividend Rate
2.48
Week52 High
134.50
Week52 Low
81.97
Avg Volume
9.64M
Shares Outstanding
1.73B
Ma50
106.29
Ma200
103.47
Earnings Date
Oct 21, 2026
Pct From52w High
-26.77%
Pct From52w Low
20.15%

Related